Author details

Full Name

Eric Wang

Affiliation

ORCID

Career Start Year

2009

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36624151	Cell-type-specific prediction of 3D chromatin organization enables high-throughput in silico genetic screening.	Nat Biotechnol	2023
34937946	Valine tRNA levels and availability regulate complex I assembly in leukaemia.	Nature	2022
35904492	Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.	Cancer Discov	2022
36138187	NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.	Nat Immunol	2022
35924979	The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation.	Cancer Discov	2022
35094009	SMARCA4 biology in alveolar rhabdomyosarcoma.	Oncogene	2022
33450187	Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.		2021
34171309	Pharmacologic modulation of RNA splicing enhances anti-tumor immunity.	Cell	2021
33846634	Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition.	Nat Genet	2021
32728019	Author Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia.	Nat Commun	2020
32434734	RNA Splicing and Cancer.		2020
31911614	Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia.	Nat Commun	2020
32444465	Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia.	Cancer Discov	2020
31048321	Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment.	Cancer Discov	2019
31767858	The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia.	Nat Commun	2019
31434609	JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.	Biochemical and Biophysical Research Communications	2019
30799057	Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.	Cancer Cell	2019
31113472	Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.	Skelet Muscle	2019
30459282	The HDAC3-SMARCA4-miR-27a axis promotes expression of the <i>PAX3:FOXO1</i> fusion oncogene in rhabdomyosarcoma.	Sci Signal	2018
28974530	Targeting the Noncoding Genome: Superenhancers Meet Their Kryptonite.	Cancer Discovery	2017
27570068	MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis.	Cell Stem Cell	2016
26447190	Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.	Blood	2015
25919951	The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer.	eLife	2015
25961408	Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains.	Nature Biotechnology	2015
26626481	NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.	Molecular Cell	2015
23412334	Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia.	Proc Natl Acad Sci U S A	2013
22469984	The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia.	Oncogene	2013
24285714	Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.	Genes Dev	2013
22106867	In vivo roles of the basic domain of dynactin p150 in microtubule plus-end tracking and dynein function.	Traffic	2012
21814200	RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.	Nature	2011
20676074	The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.	Nat Biotechnol	2010
20064463	A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit.	Molecular Cell	2009